Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Open in Screener

LXRX

Lexicon Pharmaceuticals Inc

May 06 • 04:00PM ET

1.83

Dollar change +0.09
Percentage change 5.17	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: VTI VXF IWM SCHA VTWO IWN IWO ITOT IWC VFMO

Index	RUT	P/E	-	EPS (ttm)	-0.82	Insider Own	2.74%	Shs Outstand	244.92M	Perf Week	17.31%
Market Cap	450.62M	Forward P/E	-	EPS next Y	-0.64	Insider Trans	1.50%	Shs Float	239.50M	Perf Month	-11.17%
Income	-192.07M	PEG	-	EPS next Q	-0.18	Inst Own	73.75%	Short Float	8.40%	Perf Quarter	-10.73%
Sales	2.31M	P/S	195.07	EPS this Y	10.81%	Inst Trans	18.05%	Short Ratio	4.38	Perf Half Y	30.71%
Book/sh	1.17	P/B	1.56	EPS next Y	9.77%	ROA	-66.24%	Short Interest	20.12M	Perf Year	-40.58%
Cash/sh	1.44	P/C	1.27	EPS next 5Y	-	ROE	-101.92%	52W Range	0.92 - 3.79	Perf YTD	19.61%
Dividend Est.	-	P/FCF	-	EPS past 5Y	6.80%	ROI	-48.77%	52W High	-51.70%	Beta	1.38
Dividend TTM	-	Quick Ratio	15.56	Sales past 5Y	186.21%	Gross Margin	69.62%	52W Low	98.91%	ATR (14)	0.17
Dividend Ex-Date	-	Current Ratio	15.58	EPS Y/Y TTM	-30.42%	Oper. Margin	-8045.91%	RSI (14)	50.26	Volatility	12.03% 8.15%
Employees	285	Debt/Eq	0.37	Sales Y/Y TTM	1734.13%	Profit Margin	-8311.12%	Recom	1.80	Target Price	5.25
Option/Short	Yes / Yes	LT Debt/Eq	0.36	EPS Q/Q	-16.69%	Payout	-	Rel Volume	0.51	Prev Close	1.74
Sales Surprise	-21.43%	EPS Surprise	-11.11%	Sales Q/Q	4608.33%	Earnings	May 02 AMC	Avg Volume	4.59M	Price	1.83
SMA20	4.95%	SMA50	-13.13%	SMA200	9.30%	Trades		Volume	2,336,445	Change	5.17%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-30-24	Initiated	Leerink Partners	Outperform	$5
Mar-07-23	Initiated	Jefferies	Hold	$3
Aug-12-22	Initiated	Piper Sandler	Overweight	$10
Jan-29-21	Upgrade	JP Morgan	Underweight → Neutral	$7
Jan-29-21	Downgrade	Wedbush	Outperform → Neutral	$2 → $8
Dec-08-20	Upgrade	Citigroup	Neutral → Buy
Nov-18-20	Upgrade	Gabelli & Co	Hold → Buy
Dec-11-19	Downgrade	Gabelli & Co	Buy → Hold
Nov-08-19	Downgrade	Citigroup	Buy → Neutral	$3 → $4
Sep-11-19	Upgrade	Gabelli & Co	Hold → Buy	$3
Jul-29-19	Downgrade	Stifel	Buy → Hold	$10 → $4
Mar-25-19	Upgrade	Gabelli & Co	Sell → Hold
Jul-31-18	Reiterated	Stifel	Buy	$24 → $23
Feb-23-18	Downgrade	Needham	Buy → Hold
Feb-14-18	Downgrade	JP Morgan	Neutral → Underweight	$10
Mar-01-17	Reiterated	Wedbush	Outperform	$33 → $38
Mar-01-17	Reiterated	H.C. Wainwright	Buy	$26 → $27
Oct-07-16	Initiated	H.C. Wainwright	Buy	$26
Aug-05-16	Reiterated	Wedbush	Outperform	$30 → $31
Aug-02-16	Initiated	Citigroup	Buy	$21

Show Previous Ratings

Today 10:05AM	Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Q1 2024 Earnings Call Transcript (Insider Monkey) +5.17%
May-03-24 07:46AM	Q1 2024 Lexicon Pharmaceuticals Inc Earnings Call (Thomson Reuters StreetEvents)
04:07AM	Lexicon Pharmaceuticals Inc (LXRX) Q1 2024 Earnings Call Transcript Highlights: Navigating ... (GuruFocus.com)
May-02-24 08:59PM	LXRX Stock Earnings: Lexicon Pharmaceuticals Meets EPS, Misses Revenue for Q1 2024 (InvestorPlace)
06:05PM	Lexicon Pharmaceuticals (LXRX) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
06:03PM	Loading…
06:03PM	Lexicon Pharmaceuticals Reports Q1 2024 Earnings: Aligns with EPS Projections Amidst Strategic ... (GuruFocus.com)
05:00PM	Lexicon: Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	Lexicon Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update (GlobeNewswire)
Apr-29-24 10:42AM	Lexicon Pharmaceuticals' Chief Executive Lonnel Coats to Retire (MT Newswires)
09:00AM	Lonnel Coats Retires as Chief Executive Officer and Board Member of Lexicon Pharmaceuticals (GlobeNewswire)
07:00AM	Lexicon Pharmaceuticals to Host First Quarter 2024 Financial Results Conference Call and Webcast on May 2, 2024 (GlobeNewswire)
Apr-18-24 08:00AM	Lexicon Pharmaceuticals to Host 2024 Investor Day (GlobeNewswire)
Apr-16-24 12:00PM	All You Need to Know About Lexicon (LXRX) Rating Upgrade to Buy (Zacks) -9.36%
Apr-03-24 08:00AM	Lexicon Pharmaceuticals to Participate in the 23rd Annual Needham Virtual Healthcare Conference (GlobeNewswire) -7.69%
Mar-25-24 09:20AM	Clinical Data on the Impact of Sotagliflozin on Stroke and Heart Attack Risk Among Four Lexicon-Sponsored Presentations at the American College of Cardiology 73rd Annual Scientific Session & Expo (GlobeNewswire) -6.19%
12:45PM	Loading…
Mar-13-24 12:45PM	Lexicon (LXRX) Dips on Post Hoc Analysis Data on Sotagliflozin (Zacks)
Mar-12-24 08:00AM	New Post Hoc Analysis of inTandem3 Study Demonstrates Improvements In Glycemic Control With Sotagliflozin Treatment in Patients With Type 1 Diabetes and Chronic Kidney Disease (GlobeNewswire) -10.32%
Mar-11-24 08:25AM	Lexicon Pharmaceuticals (LXRX) Reports Q4 Loss, Tops Revenue Estimates (Zacks) +29.49%
07:34AM	Lexicon: Q4 Earnings Snapshot (Associated Press Finance)
07:15AM	Lexicon Pharmaceuticals Reports Fourth Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire)
07:05AM	Lexicon Announces Oversubscribed $250 Million Private Placement of Equity Securities (GlobeNewswire)
07:00AM	Lexicon Preparing to Resubmit Sotagliflozin NDA for Type 1 Diabetes Following Feedback From FDA (GlobeNewswire)
Feb-29-24 10:00AM	Analysts Estimate Lexicon Pharmaceuticals (LXRX) to Report a Decline in Earnings: What to Look Out for (Zacks)
Feb-22-24 12:58PM	15 Hot Penny Stocks On the Move (Insider Monkey) -5.58%
Jan-31-24 05:06AM	3 Under-the-Radar Stocks With 340% to 762% Upside in 2024, According to Select Wall Street Analysts (Motley Fool) +6.25%
Jan-23-24 05:21AM	3 of the Fastest-Growing Stocks on the Planet in 2024 (Motley Fool) +15.94%
Jan-08-24 07:00AM	Lexicon Pharmaceuticals Provides Business and Pipeline Update at 42nd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-26-23 05:06AM	3 Growth Stocks Expected to Skyrocket in 2024, According to Wall Street (Motley Fool) +7.63%
Dec-21-23 04:15PM	Lexicon Pharmaceuticals To Participate In The 42nd Annual JPMorgan Healthcare Conference (GlobeNewswire)
Nov-30-23 07:30AM	Lexicon Enrolls First Patient in Phase 2b Progress Study of LX9211 in Diabetic Peripheral Neuropathic Pain (DPNP) (GlobeNewswire)
07:30AM	Loading…
Nov-22-23 07:30AM	Lexicon Pharmaceuticals to Participate in the 35th Annual Piper Sandler Healthcare Conference and the 6th Annual Evercore ISI HealthCONx Conference (GlobeNewswire)
Nov-15-23 01:03AM	Director Philippe Amouyal's Strategic 200,000 Share Purchase in Lexicon Pharmaceuticals Inc (GuruFocus.com)
Nov-12-23 02:10PM	INPEFA (sotagliflozin) Use Associated With Early Clinical Benefit in Heart Failure and Atherosclerotic Events in Analysis of Clinical Data (GlobeNewswire)
Nov-10-23 04:01PM	Lexicon Pharmaceuticals to Participate in the Jefferies London Healthcare Conference (GlobeNewswire)
10:53AM	Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-08-23 09:45PM	Q3 2023 Lexicon Pharmaceuticals Inc Earnings Call (Thomson Reuters StreetEvents) -8.80%
07:19AM	Lexicon: Q3 Earnings Snapshot (Associated Press Finance)
07:00AM	Lexicon Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire)
Nov-03-23 09:00AM	Lexicon Pharmaceuticals to Host Third Quarter 2023 Financial Results Conference Call and Webcast on November 8, 2023 (GlobeNewswire) +5.71%
Nov-02-23 09:00AM	Data on Early Clinical Benefit for INPEFA (Sotagliflozin) Will Be Among Five Lexicon-Sponsored Presentations at the American Heart Association Scientific Sessions 2023 (GlobeNewswire)
Nov-01-23 09:00AM	INPEFA (Sotagliflozin) Receives Coverage From Express Scripts on Its Basic and High Performance Formularies for Commercially Insured Patients (GlobeNewswire) +8.06%
Oct-31-23 04:01PM	Lexicon Strengthens Management Team With Two New Executives (GlobeNewswire)
Oct-30-23 04:01PM	New Data Relating to Sotagliflozin to be Presented at the American Society of Nephrology (ASN) Kidney Week 2023 Annual Meeting (GlobeNewswire) +8.11%
Oct-25-23 08:45AM	Global Diabetes Care Market Size Expected To Reach $41.71 Billion By 2027 (PR Newswire)
Oct-17-23 04:01PM	Data From Two Studies Demonstrating Positive Financial Impact of INPEFA (Sotagliflozin) to be Presented at the Academy of Managed Care Pharmacy (AMCP) Nexus 2023 National Meeting (GlobeNewswire) -8.09%
01:35PM	Hedge Fund and Insider Trading News: John Paulson, Ray Dalio, Starboard Value, Trian Fund Management, ExodusPoint Capital Management, JAT Capital, Lexicon Pharmaceuticals, Inc. (LXRX), Omnicom Group Inc. (OMC), and More (Insider Monkey)
Oct-13-23 11:38AM	Hedge Fund and Insider Trading News: Leon Cooperman, Ray Dalio, Bill Ackman, John Paulson, Altana Wealth Ltd., Apple Inc. (AAPL), Lexicon Pharmaceuticals Inc (LXRX), and More (Insider Monkey) +14.42%
Oct-11-23 11:13AM	Lexicon's (LXRX) Inpefa Gets Preferred Status at Express Scripts (Zacks)
09:00AM	Data Demonstrating Financial Impact of INPEFA (Sotagliflozin) to be Presented at the Academy of Managed Care Pharmacy (AMCP) Nexus 2023 National Meeting (GlobeNewswire)
Oct-10-23 11:25AM	Why Shares of Lexicon Pharmaceuticals Are Up Tuesday (Motley Fool) +12.00%
09:44AM	Midday movers: PepsiCo, Unity, Rivian Automotive and more (Investing.com)
03:33AM	Lexicon Pharma shares rise after Inpefa gets preferred status at Express Scripts (Investing.com)
Oct-09-23 04:01PM	INPEFA (Sotagliflozin) Receives Preferred Formulary Status With Express Scripts For Medicare Patients (GlobeNewswire) -7.41%
08:00AM	Tom Garner Joins Lexicon as Senior Vice President and Chief Commercial Officer (GlobeNewswire)
Sep-28-23 09:00AM	Lexicon to Present Post Hoc Analysis of Scored Clinical Trial at the Heart Failure Society of America (HFSA) Annual Scientific Meeting 2023 (GlobeNewswire) -9.09%
Sep-26-23 09:00AM	Lexicon to Present Study Results Relating to Sotagliflozin and LX9211 at the 59th Annual Meeting of the European Association for the Study of Diabetes (EASD) (GlobeNewswire) +10.38%
Sep-20-23 12:28PM	15 Best Affordable Stocks To Buy Under $5 (Insider Monkey)
Sep-14-23 09:40PM	Insider Buying: Jeffrey Wade Acquires 10,000 Shares of Lexicon Pharmaceuticals Inc (LXRX) (GuruFocus.com)
Sep-07-23 04:30PM	Lexicon Pharmaceuticals to Participate in the H.C. Wainwright & Co. 25th Annual Global Investment Conference (GlobeNewswire)
09:00AM	Lexicon Announces Series of Presentations Relating to LX9211, Its Investigational Drug for the Treatment of Diabetic Peripheral Neuropathic Pain (DPNP) (GlobeNewswire)
Aug-21-23 09:00AM	Lexicon to Present Analyses of INPEFA (sotagliflozin) Clinical Study Results and Changing Patterns of Heart Failure Diagnoses at the European Society of Cardiology (ESC) Congress 2023 (GlobeNewswire)
Aug-17-23 09:56AM	10 Healthcare Stocks with Insider Buying (Insider Monkey)
Aug-08-23 09:00AM	Published Analysis of Sotagliflozin (INPEFA(TM)) Clinical Data Demonstrates Significant Reductions in the Risk of Hospital Readmissions for Heart Failure (GlobeNewswire) +7.06%
Aug-04-23 09:12AM	Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) stock most popular amongst private equity firms who own 49%, while individual investors hold 25% (Simply Wall St.)
Aug-03-23 05:15PM	Lexicon Pharmaceuticals (LXRX) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:10PM	Lexicon: Q2 Earnings Snapshot (AP Finance)
04:01PM	Lexicon Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire)
Jul-28-23 04:01PM	Lexicon Pharmaceuticals to Host Second Quarter 2023 Financial Results Conference Call and Webcast on August 3, 2023 (GlobeNewswire)
08:00AM	Lexicon Elects Diane E. Sullivan to Board of Directors (GlobeNewswire)
Jun-30-23 06:52AM	Daily Vickers Top Buyers & Sellers for 06/30/2023 (Argus Research) +5.53%
Jun-27-23 06:46AM	Daily Vickers Top Buyers & Sellers for 06/27/2023 (Argus Research)
Jun-23-23 08:45PM	Lexicon Announces Planned Advancement of LX9211 Into Late-Stage Development (GlobeNewswire)
09:24AM	Daily Vickers Top Buyers & Sellers for 06/23/2023 (Argus Research)
Jun-20-23 08:00AM	Lexicon to Present Study Results Relating to LX9211 and INPEFA (Sotagliflozin) at the American Diabetes Associations 83rd Scientific Sessions (GlobeNewswire)
Jun-15-23 05:00PM	UPDATE: Lexicon Announces FDA Approval of INPEFA (sotagliflozin) for Treatment of Heart Failure (GlobeNewswire)
Jun-06-23 04:01PM	Lexicon Pharmaceuticals to Participate in the Jefferies 2023 Global Healthcare Conference (GlobeNewswire)
Jun-05-23 04:01PM	Lexicon Announces Closing of Public Offering and Concurrent Private Placement, Including Full Exercise of Options to Purchase Additional Shares (GlobeNewswire) -7.47%
Jun-04-23 07:00AM	The Word Is, 'Lexicon' Is Worth a Trade (TheStreet.com)
Jun-02-23 09:21AM	Why Lexicon Pharmaceuticals Stock Crashed This Week (Motley Fool)
Jun-01-23 11:35AM	Biotech Stock Roundup: MRTX Falls on Study Failure, LXRX Drug Wins Approval & More (Zacks) -17.88%
08:00AM	Lexicon Announces Pricing of $125 Million Public Offering and Concurrent Private Placement (GlobeNewswire)
May-31-23 04:01PM	Lexicon Announces Proposed Public Offering of Common Stock (GlobeNewswire) +13.79%
May-26-23 04:25PM	UPDATE 2-U.S. FDA approves Lexicon Pharma's drug for heart failure (Reuters) +9.66%
04:08PM	U.S. FDA approves Lexicon Pharma's heart failure drug (Reuters)
04:05PM	Lexicon Announces FDA Approval of INPEFA (sotagliflozin) for Treatment of Heart Failure (GlobeNewswire)
May-22-23 07:33AM	Weekly biotech pulse: Sana, aTyr, Theseus to release fresh data (Investing.com) +6.64%
May-11-23 06:50AM	Wall Street's Counting on an FDA Nod for This Growth Stock to Nearly Double, but Should You? (Motley Fool)
May-10-23 04:30PM	New Analysis Finds Sotagliflozin to Be a Cost-Effective Treatment at Commonly Accepted Willingness-to-Pay Threshold in Patients with Worsening Heart Failure (GlobeNewswire)
May-04-23 10:05AM	Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Q1 2023 Earnings Call Transcript (Insider Monkey) +12.41%
May-03-23 11:45AM	Q1 2023 Lexicon Pharmaceuticals Inc Earnings Call (Thomson Reuters StreetEvents) +15.13%
May-02-23 04:00PM	Lexicon Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire)
Apr-28-23 04:00PM	Lexicon Pharmaceuticals to Host First Quarter 2023 Financial Results Conference Call and Webcast on May 2, 2023 (GlobeNewswire)
Apr-22-23 08:15AM	Should You Buy This Growth Stock Right Now Before It Potentially Doubles? (Motley Fool)
Apr-21-23 09:00AM	Lexicon To Present Results From LX9211 Phase 2 Trial In Postherpetic Neuralgia At The 2023 American Academy Of Neurology (AAN) Annual Meeting And The British Pain Society (BPS) 56th Annual Scientific Meeting 2023 (GlobeNewswire)
Apr-17-23 04:00PM	Lexicon Pharmaceuticals to Participate in The 22nd Annual Needham Virtual Healthcare Conference (GlobeNewswire) +11.62%
Mar-06-23 06:00AM	Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Q4 2022 Earnings Call Transcript (Insider Monkey)
Mar-04-23 12:00PM	New Analyses of Sotagliflozin Showing Time to Clinical Benefit Presented at The American College of Cardiologys 72nd Annual Scientific Session Together With World Heart Federations World Congress of Cardiology (GlobeNewswire)
10:00AM	Lexicon Reveals INTO THE DARK Awareness Campaign About Vulnerable and Dangerous Period of Time Faced by Heart Failure Patients Following Hospitalization (GlobeNewswire)
Mar-03-23 07:07AM	Q4 2022 Lexicon Pharmaceuticals Inc Earnings Call (Thomson Reuters StreetEvents) +22.94%
Mar-02-23 04:00PM	Lexicon Pharmaceuticals Reports Fourth Quarter 2022 Financial Results and Provides Business Update (GlobeNewswire)

Lexicon Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. Its drug candidates include: LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain, and Sotagliflozin, a treatment for heart failure and type 1 diabetes. The company was founded by Brian P. Zambrowicz and Arthur T. Sands on July 7, 1995 and is headquartered in The Woodlands, TX.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
SOBECKI CHRISTOPHER J	Director	Apr 28 '24	Option Exercise	0.00	8,032	0	167,055	Apr 29 04:20 PM
Swain Judith L	Director	Apr 28 '24	Option Exercise	0.00	8,032	0	48,364	Apr 29 04:21 PM
DEBBANE RAYMOND	Director	Apr 28 '24	Option Exercise	0.00	8,032	0	1,348,879	Apr 29 04:17 PM
LEFKOWITZ ROBERT J MD	Director	Apr 28 '24	Option Exercise	0.00	8,032	0	48,364	Apr 29 04:18 PM
BARKER SAM L	Director	Apr 28 '24	Option Exercise	0.00	8,032	0	87,649	Apr 29 04:17 PM
Amouyal Philippe	Director	Apr 28 '24	Option Exercise	0.00	8,032	0	248,364	Apr 29 04:16 PM
COATS LONNEL	Chief Executive Officer	Nov 16 '23	Buy	1.05	90,000	94,797	914,359	Nov 17 04:55 PM
COATS LONNEL	Chief Executive Officer	Nov 10 '23	Buy	1.01	10,000	10,100	824,359	Nov 13 05:31 PM
DEBBANE RAYMOND	Director	Oct 12 '23	Buy	1.03	148,820	153,805	1,340,847	Oct 12 04:01 PM
DEBBANE RAYMOND	Director	Oct 11 '23	Buy	1.08	342,874	370,784	1,192,027	Oct 12 04:01 PM
DEBBANE RAYMOND	Director	Oct 10 '23	Buy	1.14	508,306	579,367	849,153	Oct 12 04:01 PM
WADE JEFFREY L	President and CFO	Sep 14 '23	Buy	1.38	10,000	13,800	264,341	Sep 14 05:05 PM
McDermott Wendy	VP, Human Resources	Aug 04 '23	Buy	1.84	6,000	11,040	28,478	Aug 07 04:13 PM
COATS LONNEL	Chief Executive Officer	Jun 29 '23	Buy	2.16	10,000	21,600	814,359	Jun 29 04:13 PM
COATS LONNEL	Chief Executive Officer	Jun 26 '23	Buy	2.18	10,000	21,792	804,359	Jun 26 04:04 PM
COATS LONNEL	Chief Executive Officer	Jun 23 '23	Buy	2.50	10,000	24,950	794,359	Jun 26 04:04 PM
McDermott Wendy	VP, Human Resources	Jun 23 '23	Buy	2.43	10,000	24,300	22,478	Jun 27 04:22 PM
COATS LONNEL	Chief Executive Officer	Jun 22 '23	Buy	2.31	40,000	92,400	784,359	Jun 22 04:01 PM
WADE JEFFREY L	President and CFO	Jun 20 '23	Buy	2.33	12,000	28,000	254,341	Jun 20 04:10 PM
Artal International S.C.A.	Director	Jun 05 '23	Buy	2.60	27,775,050	72,215,130	78,634,381	Jun 05 04:46 PM
Swain Judith L	Director	May 21 '23	Option Exercise	0.00	9,302	0	40,332	May 22 04:07 PM
NIES ALAN S	Director	May 21 '23	Option Exercise	0.00	9,302	0	41,046	May 22 04:05 PM
DEBBANE RAYMOND	Director	May 21 '23	Option Exercise	0.00	9,302	0	340,847	May 22 04:03 PM
LEFKOWITZ ROBERT J MD	Director	May 21 '23	Option Exercise	0.00	9,302	0	40,332	May 22 04:04 PM
Palantoni Frank	Director	May 21 '23	Option Exercise	0.00	9,302	0	40,332	May 22 04:06 PM
SOBECKI CHRISTOPHER J	Director	May 21 '23	Option Exercise	0.00	9,302	0	159,023	May 22 04:06 PM
Amouyal Philippe	Director	May 21 '23	Option Exercise	0.00	9,302	0	40,332	May 22 04:01 PM
BARKER SAM L	Director	May 21 '23	Option Exercise	0.00	9,302	0	79,617	May 22 04:02 PM

Open in Screener

WW

WW International Inc

May 06 • 04:00PM ET

2.05

Dollar change -0.04
Percentage change -1.91	%

Consumer Cyclical • Personal Services • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

WW WW International Inc daily Stock Chart

Held by: VTI IWM VXF IWN SCHA PRFZ VCR VTWO IWC ITOT

Index	RUT	P/E	-	EPS (ttm)	-4.32	Insider Own	1.21%	Shs Outstand	79.19M	Perf Week	10.22%
Market Cap	162.50M	Forward P/E	7.48	EPS next Y	0.27	Insider Trans	-4.57%	Shs Float	78.31M	Perf Month	23.49%
Income	-341.48M	PEG	-	EPS next Q	0.04	Inst Own	82.51%	Short Float	21.14%	Perf Quarter	-46.75%
Sales	854.20M	P/S	0.19	EPS this Y	162.28%	Inst Trans	-5.92%	Short Ratio	2.85	Perf Half Y	-75.09%
Book/sh	-14.04	P/B	-	EPS next Y	300.02%	ROA	-41.95%	Short Interest	16.56M	Perf Year	-72.96%
Cash/sh	0.84	P/C	2.44	EPS next 5Y	15.00%	ROE	-	52W Range	1.51 - 13.31	Perf YTD	-76.57%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-93.18%	52W High	-84.59%	Beta	1.75
Dividend TTM	-	Quick Ratio	0.47	Sales past 5Y	-9.97%	Gross Margin	64.65%	52W Low	35.76%	ATR (14)	0.23
Dividend Ex-Date	Dec 28, 2009	Current Ratio	0.47	EPS Y/Y TTM	16.25%	Oper. Margin	9.34%	RSI (14)	54.18	Volatility	13.42% 11.24%
Employees	4850	Debt/Eq	-	Sales Y/Y TTM	-13.28%	Profit Margin	-39.98%	Recom	2.43	Target Price	5.02
Option/Short	Yes / Yes	LT Debt/Eq	-	EPS Q/Q	-161.28%	Payout	-	Rel Volume	0.55	Prev Close	2.09
Sales Surprise	4.07%	EPS Surprise	86.58%	Sales Q/Q	-14.61%	Earnings	May 02 AMC	Avg Volume	5.81M	Price	2.05
SMA20	15.23%	SMA50	-6.50%	SMA200	-69.50%	Trades		Volume	3,198,942	Change	-1.91%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-03-24	Initiated	Barclays	Underweight	$8
Dec-20-23	Resumed	Guggenheim	Buy	$14
Sep-27-23	Upgrade	Craig Hallum	Sell → Hold	$4 → $10
Jul-26-23	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$5 → $13
Apr-11-23	Upgrade	Goldman	Neutral → Buy	$3.80 → $13
Mar-08-23	Downgrade	Craig Hallum	Hold → Sell	$4
Jan-20-22	Downgrade	KeyBanc Capital Markets	Sector Weight → Underweight	$10
Jan-11-22	Downgrade	Craig Hallum	Buy → Hold	$40 → $18
Aug-11-21	Downgrade	Jefferies	Buy → Hold	$41 → $30
Apr-08-21	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$34
Dec-15-20	Initiated	Wolfe Research	Outperform	$36
Sep-25-20	Reiterated	Citigroup	Buy	$35 → $32
Jun-16-20	Reiterated	DA Davidson	Buy	$34 → $39
Jun-12-20	Initiated	Guggenheim	Buy
May-13-20	Initiated	Jefferies	Buy	$32
Apr-29-20	Reiterated	B. Riley FBR	Buy	$28 → $30
Mar-27-20	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$24
Mar-26-20	Downgrade	Goldman	Buy → Neutral	$48 → $18
Mar-20-20	Downgrade	BofA/Merrill	Buy → Underperform
Mar-03-20	Upgrade	Citigroup	Neutral → Buy	$37

Show Previous Ratings

May-03-24 01:11PM	WW International, Inc. (NASDAQ:WW) Q1 2024 Earnings Call Transcript (Insider Monkey) +10.58%
07:11AM	Q1 2024 WW International Inc Earnings Call (Thomson Reuters StreetEvents)
May-02-24 09:57PM	WW Stock Earnings: WW International Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
06:09PM	WW International Inc (WW) Q1 2024 Earnings: Misses Revenue Estimates Amidst Strategic ... (GuruFocus.com)
04:38PM	WW International: Q1 Earnings Snapshot (Associated Press Finance)
04:08PM	Loading…
04:08PM	WW (NASDAQ:WW) Surprises With Q1 Sales (StockStory)
04:01PM	WW International, Inc. Announces First Quarter 2024 Results (GlobeNewswire)
May-01-24 04:30PM	7 Penny Stocks With the Potential to Make You an Overnight Millionaire (InvestorPlace)
12:38PM	Stock Market Crash Warning: Don't Get Caught Holding These 3 Consumer Stocks. (InvestorPlace)
09:00AM	WeightWatchers for Business and Personify Health Partner to Help Employers Address Weight Health Care (GlobeNewswire)
03:08AM	WW (WW) Q1 Earnings Report Preview: What To Look For (StockStory)
Apr-30-24 09:00AM	WeightWatchers Hosts 'Making The Shift: A New Way to Think About Weight,' A Live Virtual Event with Oprah Winfrey on Thursday, May 9 (GlobeNewswire)
Apr-25-24 10:01AM	Analysts Estimate WW International (WW) to Report a Decline in Earnings: What to Look Out for (Zacks)
Apr-22-24 02:34AM	Spotting Winners: ADT (NYSE:ADT) And Specialized Consumer Services Stocks In Q4 (StockStory)
Apr-18-24 04:01PM	WW International, Inc. Schedules First Quarter 2024 Earnings Conference Call (GlobeNewswire)
09:05AM	Loading…
Apr-11-24 09:05AM	WeightWatchers Appoints New Executive Leaders (GlobeNewswire)
Apr-09-24 05:02AM	Specialized Consumer Services Stocks Q4 Highlights: WW (NASDAQ:WW) (StockStory) +7.65%
Apr-08-24 05:08PM	Weight Watchers Creditors Prepare to Sign Cooperation Agreement (Bloomberg) +10.24%
Apr-05-24 05:48AM	Specialized Consumer Services Stocks Q4 In Review: 1-800-FLOWERS (NASDAQ:FLWS) Vs Peers (StockStory)
Mar-29-24 07:47AM	Specialized Consumer Services Stocks Q4 Results: Benchmarking LKQ (NASDAQ:LKQ) (StockStory)
Mar-14-24 09:45AM	Is WW Stock on the Brink of Bankruptcy? (InvestorPlace) -20.43%
Mar-12-24 10:28AM	25 Best Ways To Lose Weight That Actually Work (Insider Monkey) -6.97%
Mar-08-24 05:40AM	Will WW International's Bet on Ozempic Pay Off for Investors? (Motley Fool)
Mar-06-24 07:00AM	Oprahs Breakup With WeightWatchers Shows Turnaround Wont be Easy (The Wall Street Journal) -9.78%
Mar-05-24 10:39AM	WW International, Inc. (NASDAQ:WW) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-01-24 09:25AM	WW International, Inc. to Present at the Morgan Stanley Technology, Media & Telecom Conference (GlobeNewswire) +8.33%
Feb-29-24 05:17PM	WeightWatchers Stock Dives With Oprah Winfrey Leaving the Board (Investopedia) -18.22%
04:45PM	What Weighed WW International Down So Much Today (Motley Fool)
03:23PM	5 Investors Betting Big on Weight Watchers (WW) Stock as Oprah Backs Out (InvestorPlace)
12:58PM	What Oprah's board exit means for WW International (Yahoo Finance Video)
12:28PM	Loading…
12:28PM	Why WW (WW) Shares Are Sliding Today (StockStory)
12:13PM	Pure Storage, Hormel Foods rise; WW International, First Advantage fall, Thursday, 2/29/2024 (Associated Press Finance)
12:13PM	WeightWatchers tumbles after Oprah steps down from board (Associated Press Finance)
10:56AM	Oprah to exit Weight Watchers' board, stock plunges (Yahoo Finance Video)
09:30AM	Q4 2023 WW International Inc Earnings Call (Thomson Reuters StreetEvents)
08:34AM	Oprah Winfrey is leaving Weight Watchers and the stock is plummeting (Quartz)
05:54AM	WeightWatchers shares tumble as Oprah decides to exit board (Reuters)
Feb-28-24 10:05PM	Oprah will leave the Weight Watchers board and donate her stake in the company to eliminate any perceived conflict of interest around her taking weight loss medications (Fortune)
05:41PM	WW International Says Oprah Winfrey Wont Seek Re-Election to Board (The Wall Street Journal)
04:44PM	WW International Inc. Reports Mixed Results for Q4 and Full Year 2023 Amidst Strategic ... (GuruFocus.com)
04:36PM	WW (NASDAQ:WW) Reports Q4 In Line With Expectations But Stock Drops 22.8% (StockStory)
04:36PM	WW International: Q4 Earnings Snapshot (Associated Press Finance)
04:03PM	WW International, Inc. Announces Upcoming Oprah Winfrey Board Transition (GlobeNewswire)
04:01PM	WW International, Inc. Announces Fourth Quarter and Full Year 2023 Results (GlobeNewswire)
Feb-27-24 02:01AM	WW (WW) Q4 Earnings: What To Expect (StockStory) +13.35%
Feb-21-24 10:00AM	Analysts Estimate WW International (WW) to Report a Decline in Earnings: What to Look Out for (Zacks) -8.77%
Feb-17-24 05:54AM	Weight Watchers Stock: Buy, Sell, or Hold? (Motley Fool)
Feb-14-24 04:01PM	WW International, Inc. Schedules Fourth Quarter and Full Year 2023 Earnings Conference Call (GlobeNewswire)
Feb-07-24 09:05AM	Labcorp Elevates Employee Health Benefits with WeightWatchers for Business Full-Spectrum Weight Health Platform (GlobeNewswire) +6.98%
Feb-01-24 06:01AM	WeightWatchers Worst Month Ever Wipes Out Obesity-Drug Gains (Bloomberg) +5.05%
Jan-31-24 10:05AM	WW International Stock Has Lost Nearly Half Its Value in Just 1 Month: Is It a Bargain or a Bust? (Motley Fool) -6.12%
Jan-22-24 02:20PM	Why WW International Stock Bounced 6% Higher Today (Motley Fool)
Jan-21-24 10:35AM	Hot Stocks Roundup: Why Are People Talking About WW International and Zoom Video Communications Stocks Right Now? (Motley Fool)
Jan-16-24 02:04PM	Why WeightWatchers Stock Took a Dive Again Today (Motley Fool) -17.19%
09:16AM	WeightWatchers Unveils Beyond Hunger: Understanding Food Noise Report Offering Insights Into the Experience of Ongoing, Intrusive Thoughts About Food (GlobeNewswire)
Jan-11-24 06:21PM	Why WW International Stock Plummeted by 9% Today (Motley Fool) -8.77%
Jan-10-24 08:30AM	GLP-1: Beyond Diabetes, a Blockbuster Horizon Beckons (PR Newswire)
Jan-05-24 01:30PM	Why Is WeightWatchers (WW) Stock Down 5% Today? (InvestorPlace) -5.08%
08:42AM	Why WW International Stock Was Sinking Fast This Week (Motley Fool)
Jan-04-24 04:43PM	WeightWatchers Sinks as Eli Lilly Launches Weight-Loss Drug Delivery (Bloomberg) -11.13%
02:24PM	Why WW International Stock Just Dropped 11% (Motley Fool)
Dec-14-23 02:46PM	WeightWatchers launches program for weight-loss drug users after Oprah confirms GLP-1 use (Yahoo Finance) +6.38%
12:46PM	WW International now offering program with weight loss drugs (Yahoo Finance Video)
09:00AM	WeightWatchers Launches New Behavior Change Program Designed to Support the Unique Needs of Individuals on GLP-1 Medications (GlobeNewswire)
Nov-13-23 04:01PM	WW International, Inc. Announces Participation in Upcoming Investor Conferences (GlobeNewswire) -7.07%
Nov-03-23 01:48PM	WW International, Inc. (NASDAQ:WW) Q3 2023 Earnings Call Transcript (Insider Monkey) -11.06%
Nov-02-23 07:22PM	WW International Inc. Reports Q3 2023 Results: Subscriber Growth Up 6% YoY, Net Income at $43. ... (GuruFocus.com)
04:14PM	WW International: Q3 Earnings Snapshot (Associated Press Finance)
04:01PM	WW International, Inc. Announces Third Quarter 2023 Results (GlobeNewswire)
01:15PM	Why Oprah Winfreys Weight Loss Stock Is Goldmans Top Pick (Barrons.com)
Oct-27-23 02:26PM	Why WW International Stock Slipped This Week (Motley Fool)
Oct-19-23 04:01PM	WW International, Inc. Schedules Third Quarter 2023 Earnings Conference Call (GlobeNewswire) -13.40%
06:10AM	30 Celebrities Who Have Normal Jobs Now (Insider Monkey)
Oct-17-23 03:37PM	Goldman: 15 million Americans will be taking weight loss drugs by 2030 (Yahoo Finance)
Oct-13-23 01:17PM	Florine Mark, former owner of Weight Watchers franchises in Michigan and Canada, dies at 90 (Associated Press Finance)
Oct-12-23 10:35PM	Why WW International Stock Was Bulking Up This Week (Motley Fool) -10.91%
Oct-11-23 11:52AM	Novo Drugs Ozempic and Wegovy Are Shaking Up Stock Markets Again (Bloomberg)
Oct-10-23 05:02PM	WW Stock Soars To High. New Weight-Loss Drug Play Enjoys Oprah Winfrey Effect. (Investor's Business Daily) +11.85%
10:29AM	Weight-loss drugs are a boon to this surprising company (It's not who you think) (TheStreet.com)
Oct-09-23 11:57AM	Why WW International Stock Was Jumping Today (Motley Fool) +13.12%
Oct-06-23 09:15AM	WeightWatchers Enhances Enterprise Offering with Full-Spectrum Access to Weight Health (GlobeNewswire) +7.30%
Sep-27-23 10:00AM	WW upgraded, Macy's downgraded: Wall Street's top analyst calls (The Fly) +7.68%
Sep-22-23 05:42PM	Oprah calls Ozempic 'the easy way out' (Yahoo Finance Video)
Sep-19-23 08:00AM	Abbott and WeightWatchers Connected App Experience is Now Available for People Living with Diabetes (PR Newswire) +6.69%
Sep-08-23 09:00AM	WW International, Inc. Announces Participation in Upcoming Investor Conferences (GlobeNewswire)
Sep-07-23 06:34PM	10 Best Performing Small-cap ETFs in 2023 (Insider Monkey)
10:00AM	1 Weight-Loss Stock That's Been a Hotter Buy Than Eli Lilly and Novo Nordisk This Year (Motley Fool)
Aug-26-23 08:50AM	20 Best Fitness Apps in 2023 (Insider Monkey)
Aug-22-23 08:38AM	11 Best Weight Loss Stocks To Invest In (Insider Monkey)
Aug-06-23 08:47AM	Is Now An Opportune Moment To Examine WW International, Inc. (NASDAQ:WW)? (Simply Wall St.)
Aug-05-23 05:30AM	WW International, Inc. (NASDAQ:WW) Q2 2023 Earnings Call Transcript (Insider Monkey)
Aug-03-23 04:17PM	WW International: Q2 Earnings Snapshot (AP Finance)
04:05PM	William Shrank, MD, Former Chief Medical Officer at Humana, to Join WW International, Inc. Board of Directors (GlobeNewswire)
04:01PM	WW International, Inc. Announces Second Quarter 2023 Results (GlobeNewswire)
Jul-28-23 08:37AM	Why WW International Stock Was Zooming Higher This Week (Motley Fool)
Jul-26-23 01:14AM	4 big analyst picks: Meta Platforms raised to Buy ahead of Q2 (Investing.com) +16.21%
Jul-24-23 06:00AM	The end of dieting: WeightWatchers and Noom are now pushing Ozempic-like miracle drugs over willpower (Fortune) +9.22%
Jul-20-23 04:05PM	WW International, Inc. Schedules Second Quarter 2023 Earnings Conference Call (GlobeNewswire)
Jul-10-23 11:31AM	Ozempic, obesity drugs 'upending entire idea' of weight loss: Reporter (Yahoo Finance Video)
Jun-13-23 07:16AM	With 56% institutional ownership, WW International, Inc. (NASDAQ:WW) is a favorite amongst the big guns (Simply Wall St.)

WW International, Inc. engages in the provision of weight management services. It operates through the following geographical segments: North America, United Kingdom, Continental Europe and Other. The North America segment consists of United States and Canada company-owned operations. The United Kingdom segment includes United Kingdom company-owned operations. The Continental Europe segment consists of Germany, Switzerland, France, Spain, Belgium, Netherlands, and Sweden company-owned operations. The others segment offers Australia, New Zealand company-owned operations, as well as revenues and costs from franchises in the United States. The company was founded by Jean Nidetch in 1963 and is headquartered in New York, NY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
COLOSI MICHAEL F	General Counsel and Secretary	Dec 01 '23	Sale	7.04	25,900	182,245	0	Dec 04 04:20 PM
COLOSI MICHAEL F	General Counsel and Secretary	Nov 30 '23	Sale	7.22	20,000	144,314	25,900	Dec 04 04:20 PM
KELLY DENIS F	Director	May 11 '23	Buy	6.86	16,000	109,760	96,921	May 15 08:34 PM
Westend S.A.	10% Owner	May 10 '23	Sale	7.15	14,818,300	105,950,845	0	May 11 05:37 PM

affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings

LXRX

Lexicon Pharmaceuticals Inc

WW

WW International Inc

Upgrade your FINVIZ experience